ACTRN12622000495729尚未招募未知
Stereotactic Ablative Radiotherapy and T Cell Biodistribution for Oligoprogressive Head and Neck Cancer (START-HN)
Olivia Newton-John Cancer Research Institute (ONJCRI)0 个研究点目标入组 10 人开始时间: 2022年3月28日最近更新:
试验速览
- 阶段
- 未知
- 状态
- 尚未招募
- 发起方
- 入组人数
- 10
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
- 分配方式
- Non-randomised trial
- 主要目的
- Treatment
入排标准
- 年龄范围
- 18 Years 至 o limit（—）
- 性别
- All
入选标准
- •head and neck SCC with oligo-progression to 1-10 extracranial lesions, lesion size no more than 5cm and involving no more than 3 organs.
- •Sites of oligo-progressive disease can be targetable with SBRT and safely treated
- •At least one tumour lesion can be observed and will not be in the beam path of SBRT, and the observed lesion must be measurable by the criteria of RECIST version 1.1
排除标准
- •Metastatic or locoreginal disease disease invades the GI tract or large blood vessels
研究者
相似试验
进行中（未招募）
2 期
High dose Radiation therapy to eradicate early metastatic prostate cancer as an alternative to hormone or chemotherapy: a prospective phase II studyProstate CancerACTRN12618000566235Integrated Clinical Oncology Network Pty Ltd (ICON)208
已完成
2 期
Stereotactic Ablative Radiotherapy for Comprehensive Treatment of Oligometastatic Tumors (SABR-COMET): A Randomized Phase II Trialcancer spread to other parts of the bodymetastatic cancer10027476NL-OMON37922Vrije Universiteit Medisch Centrum20
招募中
不适用
Immunological effects of stereotactic radiotherapy - An exploratory trial (iDOSE)NSCLClung cancerNL-OMON54820Vrije Universiteit Medisch Centrum40
进行中（未招募）
1 期
Stereotactic body radiotherapy with immunotherapy in early stage non-small cell lung cancer: tolerability and lung effectson small-cell lung cancer (NSCLC) Stage: T1-3( =5cm)N0M0)EUCTR2016-005187-34-GBThe Royal Marsden NHS Foundation Trust31
尚未招募
不适用
Stereotactic ablative body radiotherapy for Unresectable Pancreatic cancer with Endoscopic ultrasound inserted fiducial markers and concuRrent chemotherapy (SUPER) trial.Pancreatic cancer tumoursACTRN12617001571369Royal Adelaide Hospital250